Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
RKDA

RKDA - Arcadia Biosciences Inc Stock Price, Fair Value and News

$2.18-0.05 (-2.24%)
Market Closed

71/100

RKDA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

71/100

RKDA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$3.34

Target 3M

$2.49

Target 6M

$2.75

RKDA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RKDA Price Action

Last 7 days

-3.5%

Last 30 days

-0.9%

Last 90 days

-41.2%

Trailing 12 Months

-57.2%

RKDA RSI Chart

RKDA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RKDA Valuation

Market Cap

3.0M

Price/Earnings (Trailing)

-0.6

Price/Sales (Trailing)

0.58

EV/EBITDA

-1.34

Price/Free Cashflow

-0.49

RKDA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$3.34

Target 3M

$2.49

Target 6M

$2.75

RKDA Fundamentals

RKDA Revenue

Revenue (TTM)

5.2M

Rev. Growth (Yr)

-15.29%

Rev. Growth (Qtr)

-10.52%

RKDA Earnings

Earnings (TTM)

-5.0M

Earnings Growth (Yr)

153.1%

Earnings Growth (Qtr)

119.2%

RKDA Profitability

EBT Margin

-73.58%

Return on Equity

-92.39%

Return on Assets

-58.59%

Free Cashflow Yield

-203.18%

RKDA Investor Care

Shares Dilution (1Y)

0.60%

Diluted EPS (TTM)

-3.73

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20255.3M5.4M5.2M0
20246.2M4.4M4.6M5.0M
20235.4M5.7M6.1M6.5M
20229.2M11.6M10.8M5.0M
20218.6M9.7M11.7M6.8M
20201.3M1.4M1.3M8.0M
20191.4M1.2M1.2M1.2M
20183.2M2.7M2.4M1.5M
20173.4M3.6M3.1M4.0M
20165.5M4.7M4.0M3.2M
20156.4M6.5M6.9M5.4M
20140007.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About Arcadia Biosciences Inc

RKDA
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
 CEO
 WEBSITEarcadiabio.com
 SECTORConsumer Defensive
 INDUSTRYPackaged Foods
 EMPLOYEES30

Arcadia Biosciences Inc Frequently Asked Questions

RKDA is the stock ticker symbol of Arcadia Biosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Arcadia Biosciences Inc is 2.99 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check RKDA's fair value in chart for subscribers.

The fair value guage provides a quick view whether RKDA is over valued or under valued. Whether Arcadia Biosciences Inc is cheap or expensive depends on the assumptions which impact Arcadia Biosciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RKDA.

As of Wed Jan 28 2026, RKDA's PE ratio (Price to Earnings) is -0.6 and Price to Sales (PS) ratio is 0.58. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RKDA PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Arcadia Biosciences Inc has provided -0.503 (multiply by 100 for percentage) rate of return.